GL1X · GenesisL1 explorer

MolNFT v2 · #208493 · protein

8EI3: Crystal structure of VHL in complex with H313, a Helicon Polypeptide

8EI3 · Elongin-B: “Crystal structure of VHL in complex with H313, a Helicon Polypeptide”. X-ray diffraction at 3.49, 1 ligand (WHL), 5 pockets (best druggability 0.68). MolNFT v2 #208493 on GenesisL1: 3D structure, binding sites and…

3D structure of 8EI3: Crystal structure of VHL in complex with H313, a Helicon Polypeptide (MolNFT v2 / PDB Bank)
3D structure of 8EI3: Crystal structure of VHL in complex with H313, a Helicon Polypeptide (MolNFT v2 / PDB Bank)
PDB
8EI3
Type
protein
Length
709 residues
Chains
7
Method
x-ray diffraction
Authors
Li, K., Tokareva, O.S., Thomson, T.M., Verdine, G.L., McGee, J.H.
Deposited
09/14/22
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
3.49
Source
Homo sapiens; SYNTHETIC CONSTRUCT
Molecule
Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; H313
UniProt
Q15370, Q15369, P40337
Ligands
WHL
Pockets
5 · best druggability 0.68

Structure

x-ray diffraction · resolution 3.49 · 6 distinct chains · 29% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AElongin-Bprotein10818% helix, 36% strandQ15370
B, EElongin-Cprotein8847% helix, 15% strandQ15369
Cvon Hippel-Lindau disease tumor suppressorprotein15126% helix, 28% strandP40337
DElongin-Bprotein10520% helix, 35% strandQ15370
Fvon Hippel-Lindau disease tumor suppressorprotein15228% helix, 27% strandP40337
GH313protein1776% helix, 0% strand—

Ligands and binding sites

  • WHL · N,N'-(1,4-phenylene)diacetamide · ligand · chains C, G

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18730.680.7483empty
22410.560.7840empty
31470.420.7521empty
4530.300.7614empty
5510.280.7518empty

Interfaces

8 interfaces between chains.

  • D–E · 1165 Ų buried · 14 hydrogen bonds · protein-protein
  • A–B · 1117 Ų buried · 14 hydrogen bonds · protein-protein
  • B–C · 1050 Ų buried · 15 hydrogen bonds · protein-protein
  • E–F · 1012 Ų buried · 14 hydrogen bonds · protein-protein
  • C–G · 598 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • Q15370 · AlphaFold monomer V2.0 prediction for elongin-B (Q15370) · a predicted model of the same protein · chain D against A, TM-score 0.98
  • P40337 · AlphaFold monomer V2.0 prediction for von hippel-lindau disease tumor suppressor (P40337) · a predicted model of the same protein · chain F against A, TM-score 0.98
  • Q15369 · AlphaFold monomer V2.0 prediction for elongin-C (Q15369) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.